SAINT-I worked, but the neuroprotectant is not NXY-059

被引：13

作者：

Proctor, Peter H. ^{[1
]}

Tamborello, Lynsey P.

机构：

[1] Proctor Clin, Houston, TX USA

[2] Univ Texas, Med Branch, Galveston, TX 77550 USA

来源：

STROKE | 2007年 / 38卷 / 10期

关键词：

D O I：

10.1161/STROKEAHA.107.489161

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：E109 / E109

页数：1

共 7 条

[1]

ANDERSSON M, 2003, Patent No. 20030181527

[2] N-t-butyl hydroxylamine, a hydrolysis product of α-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts [J].

Atamna, H ;

Paler-Martínez, A ;

Ames, BN .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) :6741-6748

[3]

CHAMULITRAT W, 1993, J BIOL CHEM, V268, P11520

[4]

FREDRIK C, 2004, THESIS UPSALLA U, P46

[5] Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model -: Combination studies with the thrombolytic tissue plasminogen activator [J].

Lapchak, PA ;

Chapman, DF ;

Zivin, JA .

STROKE, 2001, 32 (01) :147-153

[6] NXY-059 for acute ischemic stroke [J].

Lees, KR ;

Zivin, JA ;

Ashwood, T ;

Davalos, A ;

Davis, SM ;

Diener, H ;

Grotta, J ;

Lyden, P ;

Shuaib, A ;

Hårdemark, H ;

Wasiewski, WW .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :588-600

[7] Generation of nitric oxide from spin-trapping agents under oxidative conditions [J].

Saito, K ;

Ariga, T ;

Yoshioka, H .

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1998, 62 (02) :275-279

← 1 →